Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes
September 28, 2021 updated by: Alex Kopelowicz, M.D., University of California, Los Angeles
Using Multifamily Groups to Improve Family-Centered Self-Management of Type 2 Diabetes Among Mexican-Americans
The overall objective of this study is to construct an adaptive intervention that integrates family members and patients as partners in care while promoting diabetes self-management for Mexican Americans with Type 2 diabetes.
The project incorporates four evidence-based, culturally tailored treatments using a Sequential, Multiple Assignment Randomized Trial to help determine what sequence of intervention strategies work most efficiently and for whom.
Study Overview
Status
Completed
Conditions
Detailed Description
The project evaluates four culturally adapted, family-based treatments designed to improve health status, self-management behaviors and self-efficacy among Mexican-Americans with Type 2 diabetes using a Sequential, Multiple Assignment Randomized Trial in a public health setting.
In the first phase of the study, subjects will be randomly assigned to six 2.5 hour sessions (three months) of either: 1) Tomando Control de su Diabetes (TC), a culturally tailored, community-based, Diabetes Self-Management program delivered in a group format by community health workers (promotoras) working with individual patients and families; or 2) TC delivered by health professionals (licensed nurses).
Evaluations will be made at baseline, three months, six months and 12 months.
After six weeks of treatment (at the midway point of the intervention), subjects will be assessed for improvement in diabetes self-management behaviors (the primary outcome).
In the second phase of the study, those subjects who have improved their diabetes self-management behaviors by 50% over baseline will be continued in their assigned treatment for the duration of three months.
Those subjects who do not meet this target will be re-randomized to receive either: 1) an augmented version of TC that has a specific focus on engaging family members; or 2) a multifamily group treatment led by nurses specially trained in teaching diabetes self-management skills for an additional three months.
Study Type
Interventional
Enrollment (Actual)
330
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sylmar, California, United States, 91342
- Olive View-UCLA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mexican origin and speaks Spanish fluently
- age 18 years or older
- medical chart diagnosis of Type 2 diabetes
- living with at least one adult family member who is willing to participate.
Exclusion Criteria:
- diagnosis of Type 1 diabetes
- participation in another Diabetes Self-management education program within the past 12 months
- pregnancy
- significant cognitive impairment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tomando Control-Nurse
Tomando Control de su Diabetes-Nurse is a culturally tailored, community-based, Diabetes Self-Management program delivered in a group format by licensed nurses working with individual patients and families.
|
Tomando Control de su Diabetes-Nurse is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained Registered Nurses.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
|
|
Experimental: Tomando Control-Promotora
Tomando Control de su Diabetes-Promotora is a culturally tailored, community-based, Diabetes Self-Management program delivered in a group format by community health workers (promotoras) working with individual patients and families.
|
Tomando Control de su Diabetes-Promotora is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained promotoras.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
|
|
Experimental: Enhanced Engagement-Nurse
Tomando Control de su Diabetes-Nurse is a culturally tailored, community-based, Diabetes Self-Management program delivered in a group format by licensed nurses working with individual patients and families.
If subjects do not benefit sufficiently, the subject may be randomized to receive three home visits to facilitate engagement with treatment.
|
Tomando Control de su Diabetes-Nurse is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained Registered Nurses.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
The Tomando Control clinician (either a promotora or a Registered Nurse, depending on the original group assignment), will conduct up to three home visits that are designed to explain the purpose of the TC intervention to a key relative so as to re-engage the family member in the group process
|
|
Experimental: Enhanced Engagement-Promotora
Tomando Control de su Diabetes-Promotora is a culturally tailored, community-based, Diabetes Self-Management program delivered in a group format by licensed nurses working with individual patients and families.
If subjects do not benefit sufficiently, the subject may be randomized to receive three home visits to facilitate engagement with treatment.
|
Tomando Control de su Diabetes-Promotora is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained promotoras.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
The Tomando Control clinician (either a promotora or a Registered Nurse, depending on the original group assignment), will conduct up to three home visits that are designed to explain the purpose of the TC intervention to a key relative so as to re-engage the family member in the group process
|
|
Experimental: Multifamily Group-Promotora
If subjects do not benefit sufficiently from the initial Tomando Control intervention offered by the promotoras, they may be randomized to receive a multifamily group intervention consisting of three components: three initial "joining" sessions conducted with each of the families separately; a one-day (six hour) educational workshop; and ongoing multifamily group sessions.
|
Tomando Control de su Diabetes-Promotora is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained promotoras.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
The multifamily group consists of three components: three initial "joining" sessions conducted with each of the families separately; a one-day (six hour) educational workshop; and ongoing multifamily group sessions.
|
|
Experimental: Multifamily Group-Nurses
If subjects do not benefit sufficiently from the initial Tomando Control intervention offered by the nurses, they may be randomized to receive a multifamily group intervention consisting of three components: three initial "joining" sessions conducted with each of the families separately; a one-day (six hour) educational workshop; and ongoing multifamily group sessions.
|
Tomando Control de su Diabetes-Nurse is a community-based intervention given in six 2.5 hour sessions.
The Spanish-language sessions are led by two trained Registered Nurses.
Subjects covered in these sessions include: 1) techniques to deal with the symptoms of diabetes and associated conditions; 2) appropriate exercise; 3) healthy eating; 4) correct use of diabetes medications; and 5) working more effectively with health care providers in a collaborative partnership.
Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management strategies.
The multifamily group consists of three components: three initial "joining" sessions conducted with each of the families separately; a one-day (six hour) educational workshop; and ongoing multifamily group sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Diabetes Self-Management Behaviors (Revised Summary of Diabetes Self-Care Activities)
Time Frame: This outcome measure will be assessed at baseline, six weeks, three months, six months and 12 months. The primary outcome is change from baseline as compared to the subsequent assessment points.
|
This 11-item scale assesses ADA-recommended health activities in diet, exercise, glucose self-monitoring, medication adherence and foot care.
The mean number of days in the past week that activities are performed is calculated on a scale of 0-7; a high mean score indicates better diabetes self-management.
|
This outcome measure will be assessed at baseline, six weeks, three months, six months and 12 months. The primary outcome is change from baseline as compared to the subsequent assessment points.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes Self-Efficacy (Stanford Self-Efficacy Scale)
Time Frame: This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
An 8-item measure that assesses the confidence of a person with diabetes to manage diet, exercise, knowledge of blood glucose and the illness, and control over diabetes.
Scores range from 1-10, from no confidence to totally confident; higher scores indicate greater confidence.
|
This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
|
Diabetes knowledge (Spoken Knowledge in Low Literacy Patients with Diabetes scale)
Time Frame: This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
This 10-item scale assesses knowledge of glucose management, lifestyle modifications, recognition and treatment of hyper- and hypoglycemia, and activities to prevent long-term consequences of the disease.
Correct answers receive a score of 1.
Each item score is summed ranging from 0-10, with a high score indicating better knowledge about diabetes.
|
This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
|
Family Support (Diabetes Family Support Behavior Checklist)
Time Frame: This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
This 17-item scale uses a 5-point Likert range to assess perceptions of family member support of the person with T2DM in medication taking, glucose self-monitoring, exercise and diet.
Positive and negative items are summed separately and higher scores indicate stronger perception of family support.
|
This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
|
Collaborative goal setting (Patient Assessment of Chronic Illness Care)
Time Frame: This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
A 20-item patient survey that evaluates the quality and patient centeredness of chronic illness care received according to the Chronic Care Model paradigm.
The questionnaire is divided into five subscales to reflect the key components of the Chronic Care Model: patient activation, delivery system design & decision support, goal setting & tailoring, problem-solving & contextual, and follow-up/coordination.
Each item has a score from 1 (never) to 5 (always).
Patients self-report how often they received specific types of medical care during the past six months.
|
This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
|
Glycemic control
Time Frame: This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
Hemoglobin A1c serum level
|
This outcome measure will be assessed at baseline, three months, six months and 12 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: alex kopelowicz, MD, Olive View-UCLA Education & Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2017
Primary Completion (Actual)
December 31, 2020
Study Completion (Actual)
July 31, 2021
Study Registration Dates
First Submitted
March 10, 2017
First Submitted That Met QC Criteria
March 21, 2017
First Posted (Actual)
March 27, 2017
Study Record Updates
Last Update Posted (Actual)
September 29, 2021
Last Update Submitted That Met QC Criteria
September 28, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5R01NR015809 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.